This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by SCHADE, D. S. Articles by EATON, R. P. Search for Related Content PubMed PubMed Citation Articles by SCHADE, D. S. Articles by EATON, R. P.

Dose Response to Insulin in Man: Differential Effects on Glucose and Ketone Body Regulation

Department of Medicine, University of New Mexico School of Medicine, Albuquerque New Mexico 87131

This prospective study was undertaken to elucidate the relationship between progressive log increments in plasma free insulin concentration and the resultant changes in the concentrations of plasma glucose, potassium, ketones, and free fatty acids in man. We attempted to define both the maximal and minimal threshold for substrate response relative to circulating concentrations of plasma insulin. Hyperglycemia and hyperketonemia were experimentally induced with dexamethasone in six diabetic subjects. Circulating plasma insulin concentration was acutely elevated by the continuous iv infusion of insulin in order to attain ten-fold increments in circulating plasma insulin concentration. Specifically, following a progressive elevation above basal concentration, maximal increments in circulating plasma insulin of 7 µU/ml, 90µU/ml, and 1, 621 µU/ml were obtained. The differential effects of these acute alterations in plasma insulin concentration on plasma substrate concentrations were compared to a controlsaline infusion study. The maximal rate of reduction in the plasma concentration of glucose and potassium was observed during pharmacological circulating concentrations of insulin (< 1, 000 µU/ml). This response contrasted to that observed for plasma ketone body and free fatty acid concentration. For these substrates, the maximal rate of reduction was observed during physiological increments in plasma insulin concentration (less than 90 µU/ml). While this dissociation of response in terms of plasma glucose, fatty acids, and ketones to insulin characterizes steroid-induced hyperglycemia and hyperketonemia, it is probable that a comparable dissociation may apply to other pathological stressinduced states.

Supported by a grant from the American Diabetes Association, The KROC Foundation, and the Eli Lilly Company

Received October 12, 1976.

This article has been cited by other articles:

				P. B. Koul Diabetic Ketoacidosis: A Current Appraisal of Pathophysiology and Management Clinical Pediatrics, March 1, 2009; 48(2): 135 - 144. [Abstract] [PDF]

				J. Wolfsdorf, N. Glaser, and M. A. Sperling Diabetic Ketoacidosis in Infants, Children, and Adolescents: A consensus statement from the American Diabetes Association Diabetes Care, May 1, 2006; 29(5): 1150 - 1159. [Full Text] [PDF]

				D B Dunger, M A Sperling, C L Acerini, D J Bohn, D Daneman, T P A Danne, N S Glaser, R Hanas, R L Hintz, L L Levitsky, et al. ESPE/LWPES consensus statement on diabetic ketoacidosis in children and adolescents Arch. Dis. Child., February 1, 2004; 89(2): 188 - 194. [Abstract] [Full Text]

				D. B. Dunger, M. A. Sperling, C. L. Acerini, D. J. Bohn, D. Daneman, T. P.A. Danne, N. S. Glaser, R. Hanas, R. L. Hintz, L. L. Levitsky, et al. European Society for Paediatric Endocrinology/Lawson Wilkins Pediatric Endocrine Society Consensus Statement on Diabetic Ketoacidosis in Children and Adolescents Pediatrics, February 1, 2004; 113(2): e133 - 140. [Full Text] [PDF]

				K Foo, N Sekhri, A Deaner, C Knight, A Suliman, K Ranjadayalan, and A D Timmis Effect of diabetes on serum potassium concentrations in acute coronary syndromes Heart, January 1, 2003; 89(1): 31 - 35. [Abstract] [Full Text] [PDF]

				G. E. Umpierrez, M. B. Murphy, and A. E. Kitabchi Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar Syndrome Diabetes Spectr, January 1, 2002; 15(1): 28 - 36. [Abstract] [Full Text] [PDF]

				A. E. Kitabchi, G. E. Umpierrez, M. B. Murphy, E. J. Barrett, R. A. Kreisberg, J. I. Malone, and B. M. Wall Management of Hyperglycemic Crises in Patients With Diabetes Diabetes Care, January 1, 2001; 24(1): 131 - 153. [Full Text]

				R. Alemzadeh, G. Langley, L. Upchurch, P. Smith, and A. E. Slonim Beneficial Effect of Diazoxide in Obese Hyperinsulinemic Adults J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 1911 - 1915. [Abstract] [Full Text]

				S. N. Levine and J. E. Loewenstein Treatment of Diabetic Ketoacidosis Arch Intern Med, May 1, 1981; 141(6): 713 - 715. [Abstract] [PDF]

				D. S. Schade and R. P. Eaton Differential Diagnosis and Therapy of Hyperketonemic State JAMA, May 11, 1979; 241(19): 2064 - 2065. [Abstract] [PDF]

				R. A. KREISBERG Diabetic Ketoacidosis: New Concepts and Trends in Pathogenesis and Treatment Ann Intern Med, May 1, 1978; 88(5): 681 - 695. [Abstract] [PDF]